Volume 2 Issue 1

Mini-Review: Microbial Endocrinology in Microbiology: A Mini-Review

Michael AB. Naafs*

Microbial endocrinology represents the intersection of two seemingly desparate fields, microbiology and neurobiology. Current research developments in intestinal microbiota and microbial endocrinology are considered. Its relationship with behavior, metabolism and a variety of diseases are discussed. Pathogenesis, pathophysiology and possible therapeutic applications to the intestinal microbiome communities are reviewed.

Cite this Article: Naafs MAB. Microbial Endocrinology in Microbiology: A Mini-Review. Int J Clin Endocrinol. 2018;2(1): 004-010.

Published: 25 January 2018

Editorial: Individualized Dosing of Denosumab for the Treatment of Osteoporosis

Derick Adams*

Denosumab is a potent monoclonal antibody which inactivates the RANK ligand. Inactivation of RANK ligand leads to the inhibition of osteoclast activity and maturation which decreases bone resorption. Denosumab is a potent antiresorptive that has been shown to dramatically suppress bone turnover markers, maintain bone mineral density, and prevent fractures [1].

Cite this Article: Adams D. Individualized Dosing of Denosumab for the Treatment of Osteoporosis. Int J Clin Endocrinol. 2018;2(1): 001-003.

Published: 12 January 2018

Submit ManuscriptSubmit Special Issue

Authors submit all Proposals and manuscripts via Electronic Form!

All Journals

Creative Commons License Open Access by SciRes Literature is licensed under a Creative Commons Attribution 4.0 International License. Based on a work at www.scireslit.com.